Ironically Z, you have answered my question for me. Thanks. :)
The reason the buyback hasn't begun already is it would force the CFE price up, and hence increase the likelihood that COV holders would accept the scrip offer. And CFE doesn't want that...
So, as has been pointed out on the COV thread, there may be an arbitrage whereby (in small volumes) you can pick up 'de facto CFE scrip' cheaper than on the market by buying COV. Hardly worth bothering with though...
But the COV directors won't want to lose their jobs, so they won't accept the offer...
Once the silly charade of this ASIC-enforced takeover bid is done with, I suspect the buy back may begin.
In the meantime, CFE will have a steady stream of good news, as the values of various assets are crystallised.
Y
- Forums
- ASX - By Stock
- CLE
- share buy back
share buy back, page-7
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CLE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.73M |
Open | High | Low | Value | Volume |
0.1¢ | 0.2¢ | 0.1¢ | $80.35K | 80.33M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 31658116 | 0.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.2¢ | 115578703 | 44 |
Last trade - 15.55pm 01/11/2024 (20 minute delay) ? |
Featured News
CLE (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online